10 20 30 40 50 60 70 80 1OL9 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER RECEPTOR 06-AUG-03 1OL9
TITLE EPIBATIDINE BOUND ON A MODEL OF CHICK ALPHA7 NICOTINIC TITLE 2 RECEPTORS
COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN, ALPHA-7 COMPND 3 CHAIN; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: EXTRACELLULAR DOMAIN, RESIDUES 24-230; COMPND 6 SYNONYM: NICOTINIC ACETYLCHOLINE RECEPTOR ALPHA7
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN
KEYWDS NICOTINIC RECEPTOR, ACETYCHOLINE RECEPTOR, EPIBATIDINE
EXPDTA THEORETICAL MODEL
AUTHOR N.LE NOVERE
REVDAT 1 18-AUG-03 1OL9 0
JRNL AUTH N.LE NOVERE,T.GRUTTER,J.-P.CHANGEUX JRNL TITL MODELS OF THE EXTRACELLULAR DOMAIN OF THE JRNL TITL 2 NICOTINIC RECEPTORS AND OF AGONIST AND CA++ JRNL TITL 3 BINDING SITES JRNL REF PROC.NATL.ACAD.SCI.USA V. 99 3210 2002 JRNL REFN ASTM PNASA6 US ISSN 0027-8424
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1OL9 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY EBI ON 6-AUG-2003. REMARK 100 THE EBI ID CODE IS EBI-13258.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTIONS BY UNDERGOING AN EXTENSIVE CONFORMATIONAL CHANGE REMARK 400 AFTER BINDING ACETYLCHOLINE THAT AFFECTS ALL SUBUNITS AND REMARK 400 LEADS TO OPENING OF AN ION-CONDUCTING CHANNEL ACROSS THE REMARK 400 PLASMA MEMBRANE.
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 0 REMARK 465 GLU B 0
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 15 N - CA - C ANGL. DEV. = 15.5 DEGREES REMARK 500 ALA A 94 N - CA - C ANGL. DEV. =-15.5 DEGREES REMARK 500 PRO B 15 N - CA - C ANGL. DEV. = 14.3 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 136 173.91 94.39
REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 SITE_DESCRIPTION: EPJ BINDING SITE FOR CHAIN A
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1KC4 RELATED DB: PDB REMARK 900 NMR STRUCTURAL ANALYSIS OF THE COMPLEX REMARK 900 FORMED BETWEEN ALPHA-BUNGAROTOXIN AND THE REMARK 900 PRINCIPAL ALPHA-NEUROTOXIN BINDINGSEQUENCE ON REMARK 900 THE ALPHA7 SUBUNIT OF A NEURONAL REMARK 900 NICOTINICACETYLCHOLINE RECEPTOR REMARK 900 RELATED ID: 1KL8 RELATED DB: PDB REMARK 900 NMR STRUCTURAL ANALYSIS OF THE COMPLEX REMARK 900 FORMED BETWEEN ALPHA-BUNGAROTOXIN AND THE REMARK 900 PRINCIPAL ALPHA-NEUROTOXIN BINDINGSEQUENCE ON REMARK 900 THE ALPHA7 SUBUNIT OF A NEURONAL REMARK 900 NICOTINICACETYLCHOLINE RECEPTOR REMARK 900 RELATED ID: 1OL3 RELATED DB: PDB REMARK 900 MODEL OF CHICK ALPHA7 NICOTINIC RECEPTORS REMARK 900 RELATED ID: 1OL4 RELATED DB: PDB REMARK 900 ACETYLCHOLINE BOUND TO CHICK ALPHA7 NICOTINIC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1OL8 RELATED DB: PDB REMARK 900 NICOTINE BOUND ON A MODEL OF CHICK ALPHA7 REMARK 900 NICOTINIC RECEPTORS
DBREF 1OL9 A 0 206 UNP P22770 ACH7_CHICK 24 230 DBREF 1OL9 B 0 206 UNP P22770 ACH7_CHICK 24 230
SEQRES 1 A 207 GLU PHE GLN ARG LYS LEU TYR LYS GLU LEU LEU LYS ASN SEQRES 2 A 207 TYR ASN PRO LEU GLU ARG PRO VAL ALA ASN ASP SER GLN SEQRES 3 A 207 PRO LEU THR VAL TYR PHE THR LEU SER LEU MET GLN ILE SEQRES 4 A 207 MET ASP VAL ASP GLU LYS ASN GLN VAL LEU THR THR ASN SEQRES 5 A 207 ILE TRP LEU GLN MET TYR TRP THR ASP HIS TYR LEU GLN SEQRES 6 A 207 TRP ASN VAL SER GLU TYR PRO GLY VAL LYS ASN VAL ARG SEQRES 7 A 207 PHE PRO ASP GLY LEU ILE TRP LYS PRO ASP ILE LEU LEU SEQRES 8 A 207 TYR ASN SER ALA ASP GLU ARG PHE ASP ALA THR PHE HIS SEQRES 9 A 207 THR ASN VAL LEU VAL ASN SER SER GLY HIS CYS GLN TYR SEQRES 10 A 207 LEU PRO PRO GLY ILE PHE LYS SER SER CYS TYR ILE ASP SEQRES 11 A 207 VAL ARG TRP PHE PRO PHE ASP VAL GLN LYS CYS ASN LEU SEQRES 12 A 207 LYS PHE GLY SER TRP THR TYR GLY GLY TRP SER LEU ASP SEQRES 13 A 207 LEU GLN MET GLN GLU ALA ASP ILE SER GLY TYR ILE SER SEQRES 14 A 207 ASN GLY GLU TRP ASP LEU VAL GLY ILE PRO GLY LYS ARG SEQRES 15 A 207 THR GLU SER PHE TYR GLU CYS CYS LYS GLU PRO TYR PRO SEQRES 16 A 207 ASP ILE THR PHE THR VAL THR MET ARG ARG ARG THR SEQRES 1 B 207 GLU PHE GLN ARG LYS LEU TYR LYS GLU LEU LEU LYS ASN SEQRES 2 B 207 TYR ASN PRO LEU GLU ARG PRO VAL ALA ASN ASP SER GLN SEQRES 3 B 207 PRO LEU THR VAL TYR PHE THR LEU SER LEU MET GLN ILE SEQRES 4 B 207 MET ASP VAL ASP GLU LYS ASN GLN VAL LEU THR THR ASN SEQRES 5 B 207 ILE TRP LEU GLN MET TYR TRP THR ASP HIS TYR LEU GLN SEQRES 6 B 207 TRP ASN VAL SER GLU TYR PRO GLY VAL LYS ASN VAL ARG SEQRES 7 B 207 PHE PRO ASP GLY LEU ILE TRP LYS PRO ASP ILE LEU LEU SEQRES 8 B 207 TYR ASN SER ALA ASP GLU ARG PHE ASP ALA THR PHE HIS SEQRES 9 B 207 THR ASN VAL LEU VAL ASN SER SER GLY HIS CYS GLN TYR SEQRES 10 B 207 LEU PRO PRO GLY ILE PHE LYS SER SER CYS TYR ILE ASP SEQRES 11 B 207 VAL ARG TRP PHE PRO PHE ASP VAL GLN LYS CYS ASN LEU SEQRES 12 B 207 LYS PHE GLY SER TRP THR TYR GLY GLY TRP SER LEU ASP SEQRES 13 B 207 LEU GLN MET GLN GLU ALA ASP ILE SER GLY TYR ILE SER SEQRES 14 B 207 ASN GLY GLU TRP ASP LEU VAL GLY ILE PRO GLY LYS ARG SEQRES 15 B 207 THR GLU SER PHE TYR GLU CYS CYS LYS GLU PRO TYR PRO SEQRES 16 B 207 ASP ILE THR PHE THR VAL THR MET ARG ARG ARG THR
HET EPJ A1207 15
HETNAM EPJ EPIBATIDINE
HETSYN EPJ (2R)-2-(6-CHLOROPYRIDIN-3-YL)-7- HETSYN 2 EPJ AZABICYCLO[2.2.1]HEPTANE
FORMUL 3 EPJ C11 H13 CL N2
HELIX 1 1 GLN A 2 TYR A 13 1 12 HELIX 2 2 HIS A 61 GLN A 64 5 4 HELIX 3 3 GLY A 81 ILE A 83 5 3 HELIX 4 4 GLN B 2 TYR B 13 1 12 HELIX 5 5 HIS B 61 GLN B 64 5 4 HELIX 6 6 GLY B 81 ILE B 83 5 3
SHEET 1 AA 6 VAL A 76 PRO A 79 0 SHEET 2 AA 6 ASN A 105 VAL A 108 -1 O VAL A 106 N PHE A 78 SHEET 3 AA 6 HIS A 113 TYR A 116 -1 O GLN A 115 N LEU A 107 SHEET 4 AA 6 VAL A 47 THR A 59 -1 O MET A 56 N TYR A 116 SHEET 5 AA 6 LEU A 27 ASP A 42 -1 O TYR A 30 N TYR A 57 SHEET 6 AA 6 LEU A 154 GLN A 157 1 O ASP A 155 N VAL A 29 SHEET 1 AB 6 VAL A 76 PRO A 79 0 SHEET 2 AB 6 ASN A 105 VAL A 108 -1 O VAL A 106 N PHE A 78 SHEET 3 AB 6 HIS A 113 TYR A 116 -1 O GLN A 115 N LEU A 107 SHEET 4 AB 6 VAL A 47 THR A 59 -1 O MET A 56 N TYR A 116 SHEET 5 AB 6 PRO A 119 SER A 125 -1 O GLY A 120 N ILE A 52 SHEET 6 AB 6 ASP A 99 ALA A 100 -1 O ASP A 99 N ILE A 121 SHEET 1 AC 4 ILE A 88 LEU A 90 0 SHEET 2 AC 4 VAL A 137 SER A 146 -1 O GLY A 145 N LEU A 89 SHEET 3 AC 4 PRO A 192 ARG A 204 -1 O ILE A 196 N PHE A 144 SHEET 4 AC 4 TRP A 172 GLY A 176 -1 O ASP A 173 N ARG A 203 SHEET 1 AD 4 ILE A 88 LEU A 90 0 SHEET 2 AD 4 VAL A 137 SER A 146 -1 O GLY A 145 N LEU A 89 SHEET 3 AD 4 PRO A 192 ARG A 204 -1 O ILE A 196 N PHE A 144 SHEET 4 AD 4 GLY A 179 PHE A 185 -1 O LYS A 180 N THR A 197 SHEET 1 BA 6 VAL B 76 PRO B 79 0 SHEET 2 BA 6 ASN B 105 VAL B 108 -1 O VAL B 106 N PHE B 78 SHEET 3 BA 6 HIS B 113 TYR B 116 -1 O GLN B 115 N LEU B 107 SHEET 4 BA 6 VAL B 47 THR B 59 -1 O MET B 56 N TYR B 116 SHEET 5 BA 6 LEU B 27 ASP B 42 -1 O TYR B 30 N TYR B 57 SHEET 6 BA 6 LEU B 154 GLN B 157 1 O ASP B 155 N VAL B 29 SHEET 1 BB 6 VAL B 76 PRO B 79 0 SHEET 2 BB 6 ASN B 105 VAL B 108 -1 O VAL B 106 N PHE B 78 SHEET 3 BB 6 HIS B 113 TYR B 116 -1 O GLN B 115 N LEU B 107 SHEET 4 BB 6 VAL B 47 THR B 59 -1 O MET B 56 N TYR B 116 SHEET 5 BB 6 PRO B 119 SER B 125 -1 O GLY B 120 N ILE B 52 SHEET 6 BB 6 ASP B 99 ALA B 100 -1 O ASP B 99 N ILE B 121 SHEET 1 BC 7 ILE B 88 LEU B 90 0 SHEET 2 BC 7 VAL B 137 SER B 146 -1 O GLY B 145 N LEU B 89 SHEET 3 BC 7 PRO B 192 ARG B 204 -1 O ILE B 196 N PHE B 144 SHEET 4 BC 7 TRP B 172 GLY B 176 -1 O ASP B 173 N ARG B 203 SHEET 5 BC 7 PRO B 192 ARG B 204 -1 O THR B 201 N GLY B 176 SHEET 6 BC 7 GLY B 179 PHE B 185 -1 O LYS B 180 N THR B 197 SHEET 7 BC 7 PRO B 192 ARG B 204 -1 O TYR B 193 N SER B 184
SSBOND 1 CYS A 126 CYS A 140 SSBOND 2 CYS A 188 CYS A 189 SSBOND 3 CYS B 126 CYS B 140 SSBOND 4 CYS B 188 CYS B 189
SITE 1 AC1 5 TYR A 91 TRP A 147 THR A 148 TYR A 186 SITE 2 AC1 5 LEU B 107
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000